What are the untapped areas of opportunity in Oncology?
In Kaiser's 2018 Hot Indications list, Oncology remains in the top spot as the highest ranked therapeutic area. 2017 was characterized by pivotal investments, major innovations, and continued M&A and partnership activities in this space. As large markets continue to get more competitive, companies are pursuing attractive opportunities in rare and neglected cancers.
This Deep Dive includes:
- Update on major developments in Oncology
- Analysis of future Hot Indications in Oncology
- Insights on acquisitions, drug approvals, and pipeline activity
Complete the form to download our Oncology Deep Dive.
Have you seen our full list of 2018 Hot Indications? Click here to see this year's list.